Clinical trial
The Berlin 'Cream&Sugar' Study: the Prognostic Impact of an Oral Triglyceride Tolerance Test in Patients After Acute Ischemic Stroke
NCT01378468 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Berlin 'Cream&Sugar' Study: the Prognostic Impact of an Oral Triglyceride Tolerance Test in Patients After Acute Ischemic Stroke
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2009
- Completion date
- July 31, 2017
- Enrollment
- 573 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
first ischemic stroke